AdvisorShares Trust 13D and 13G filings for Enveric Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-02 4:12 pm Purchase |
2025-03-31 | 13G | Enveric Biosciences, Inc. ENVB |
AdvisorShares Trust | 90,324 3.650% |
87,658 (+3287.97%) |
Filing |
| 2025-01-06 5:04 pm Purchase |
2024-12-31 | 13G | Enveric Biosciences, Inc. ENVB |
AdvisorShares Trust | 2,666 5.900% |
1,035 (+63.43%) |
Filing |
| 2024-11-12 1:43 pm Purchase |
2024-09-30 | 13G | Enveric Biosciences, Inc. ENVB |
AdvisorShares Trust | 1,631 4.110% |
1,114 (+215.62%) |
Filing |
| 2023-02-14 5:02 pm Purchase |
2022-12-31 | 13G | Enveric Biosciences, Inc. ENVB |
AdvisorShares Trust | 517 5.600% |
517 (New Position) |
Filing |